Global Markets Direct’s, ‘Anesthetic Effect - Pipeline Review, H2 2018’, provides an overview of the Anesthetic Effect pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Anesthetic Effect, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Anesthetic Effect and features dormant and discontinued projects.
Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.
Scope
- The report provides a snapshot of the global therapeutic landscape of Anesthetic Effect
- The report reviews pipeline therapeutics for Anesthetic Effect by companies and universities/research institutes based on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved Anesthetic Effect therapeutics and enlists all their major and minor projects
- The report assesses Anesthetic Effect therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews latest news related to pipeline therapeutics for Anesthetic Effect
Reasons to buy
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Anesthetic Effect
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Anesthetic Effect pipeline depth and focus of Indication therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
Companies mentioned
Biolab Farmaceutica Ltda
Crescita Therapeutics Inc
Drawbridge Pharmaceuticals Pty Ltd
Expanesthetics Inc
Grunenthal GmbH
Lannett Company Inc
Lee's Pharmaceutical Holdings Ltd
MedinCell SA
Paion AG ...
Biolab Farmaceutica Ltda
Crescita Therapeutics Inc
Drawbridge Pharmaceuticals Pty Ltd
Expanesthetics Inc
Grunenthal GmbH
Lannett Company Inc
Lee's Pharmaceutical Holdings Ltd
MedinCell SA
Paion AG
Phosphagenics Ltd
Physica Pharma
Recro Pharma Inc
Sichuan Kelun Pharmaceutical Co Ltd
SiteOne Therapeutics Inc
Sphaera Pharma Pte Ltd
YiChang Humanwell Pharmaceutical Co Ltd
Table of Contents
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Anesthetic Effect – Overview
Anesthetic Effect – Therapeutics Development
Pipeline Overview
Pipeline ...
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Anesthetic Effect – Overview
Anesthetic Effect – Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Anesthetic Effect – Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Anesthetic Effect – Companies Involved in Therapeutics Development
Biolab Farmaceutica Ltda
Crescita Therapeutics Inc
Drawbridge Pharmaceuticals Pty Ltd
Expanesthetics Inc
Grunenthal GmbH
Lannett Company Inc
Lee's Pharmaceutical Holdings Ltd
MedinCell SA
Paion AG
Phosphagenics Ltd
Physica Pharma
Recro Pharma Inc
Sichuan Kelun Pharmaceutical Co Ltd
SiteOne Therapeutics Inc
Sphaera Pharma Pte Ltd
YiChang Humanwell Pharmaceutical Co Ltd
Anesthetic Effect – Drug Profiles
(bupivacaine + neosaxitoxin) – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
(lidocaine + prilocaine) – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
alphaxalone – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Aom-0498 – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Aom-0765 – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
cocaine hydrochloride – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
cysteine – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
EXPS-01 – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
EXPS-05 – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
EXPS-09 – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Flexicaine – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
fospropofol disodium – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
HSK-3486 – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
KL-100137 – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
lidocaine – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
lidocaine hydrochloride – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
MDC-CMV – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
PHY-301 – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
propofol – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
propofol – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
propofol – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
propofol – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
remimazolam – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
RP-2000 – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules to Block NaV1.7 for Local Anesthetic Effect – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules to Inhibit NMDA Receptor for Anesthesia – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
SPR-819 – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Anesthetic Effect – Dormant Projects
Anesthetic Effect – Discontinued Products
Anesthetic Effect – Product Development Milestones
Featured News & Press Releases
Oct 08, 2018: PAION announces clinical development progress with Remimazolam by its partner Hana Pharm in South Korea
Jul 24, 2018: PAION starts EU Phase III trial with remimazolam in general anesthesia
Apr 30, 2018: Recro Pharma Presents Data for Neuromuscular Blocking and Reversal Agents at the AUA 2018 Annual Meeting
Mar 20, 2018: Phosphagenics/Terumo R&D alliance to focus on TPM Injectables: TPM/Oxymorphone Patch Development to move outside Agreement
Nov 23, 2017: PAION Announces Clinical Development Progress with Remimazolam by its Partner Hana Pharma in South Korea
Nov 09, 2017: Phosphagenics Provides Update on TPM/Propofol Development Program
Sep 28, 2017: European Patent Office Grants Formulation Patent For Remimazolam In The EU
Mar 09, 2017: China FDA has Approved Zingo for Pediatric Use Needle-free Local Analgesia as Priority Review for Clinical Trial
Nov 14, 2016: Powder Pharmaceuticals Submits New Drug Application to China FDA and Hong Kong Department of Health for Needle-free Local Analgesia
Oct 19, 2016: Positive Remimazolam Phase III Colonoscopy Results Presented at the 2016 American College of Gastroenterology Annual Scientific Meeting
Sep 22, 2016: PAION: Remimazolam Phase III Colonoscopy Data to Be Presented at the American College of Gastroenterology 2016 Meeting
Sep 06, 2016: PAION announces clinical development progress with remimazolam by its Partner Yichang Humanwell in China
Jun 19, 2016: Paion Reports Positive Remimazolam Headline Data In Pivotal U.S. Phase III Study In Procedural Sedation For Colonoscopy
Feb 18, 2016: PAION reports about positive pre-NDA meeting with Japanese authority PMDA
Feb 09, 2016: Paion Discontinues European Remimazolam Phase III Trial In Cardiac Surgery Patients Due To Insufficient Recruitment
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
List of Tables
Number of Products under Development for Anesthetic Effect, H2 2018
Number of Products under Development by Companies, H2 2018
Number of Products ...
List of Tables
Number of Products under Development for Anesthetic Effect, H2 2018
Number of Products under Development by Companies, H2 2018
Number of Products under Development by Universities/Institutes, H2 2018
Products under Development by Companies, H2 2018
Products under Development by Companies, H2 2018 (Contd..1), H2 2018
Products under Development by Universities/Institutes, H2 2018
Number of Products by Stage and Target, H2 2018
Number of Products by Stage and Mechanism of Action, H2 2018
Number of Products by Stage and Route of Administration, H2 2018
Number of Products by Stage and Molecule Type, H2 2018
Anesthetic Effect – Pipeline by Biolab Farmaceutica Ltda, H2 2018
Anesthetic Effect – Pipeline by Crescita Therapeutics Inc, H2 2018
Anesthetic Effect – Pipeline by Drawbridge Pharmaceuticals Pty Ltd, H2 2018
Anesthetic Effect – Pipeline by Expanesthetics Inc, H2 2018
Anesthetic Effect – Pipeline by Grunenthal GmbH, H2 2018
Anesthetic Effect – Pipeline by Lannett Company Inc, H2 2018
Anesthetic Effect – Pipeline by Lee's Pharmaceutical Holdings Ltd, H2 2018
Anesthetic Effect – Pipeline by MedinCell SA, H2 2018
Anesthetic Effect – Pipeline by Paion AG, H2 2018
Anesthetic Effect – Pipeline by Phosphagenics Ltd, H2 2018
Anesthetic Effect – Pipeline by Physica Pharma, H2 2018
Anesthetic Effect – Pipeline by Recro Pharma Inc, H2 2018
Anesthetic Effect – Pipeline by Sichuan Kelun Pharmaceutical Co Ltd, H2 2018
Anesthetic Effect – Pipeline by SiteOne Therapeutics Inc, H2 2018
Anesthetic Effect – Pipeline by Sphaera Pharma Pte Ltd, H2 2018
Anesthetic Effect – Pipeline by YiChang Humanwell Pharmaceutical Co Ltd, H2 2018
Anesthetic Effect – Dormant Projects, H2 2018
Anesthetic Effect – Dormant Projects, H2 2018 (Contd..1), H2 2018
Anesthetic Effect – Discontinued Products, H2 2018
List of Figures
List of Figures
Number of Products under Development for Anesthetic Effect, H2 2018
Number of Products under Development by Companies, H2 2018
Number of Products ...
List of Figures
Number of Products under Development for Anesthetic Effect, H2 2018
Number of Products under Development by Companies, H2 2018
Number of Products by Top 10 Targets, H2 2018
Number of Products by Stage and Top 10 Targets, H2 2018
Number of Products by Top 10 Mechanism of Actions, H2 2018
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2018
Number of Products by Routes of Administration, H2 2018
Number of Products by Stage and Routes of Administration, H2 2018
Number of Products by Stage and Molecule Types, H2 2018